AGMB AgomAb Therapeutics NV

NASDAQ

$8.40

AgomAb Therapeutics NV (AGMB) Earnings News

Earnings press releases, previews and reviews for AgomAb Therapeutics NV (AGMB), newest first.

Thursday August 6, 2026 4:01 PM ET

Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook

Wednesday May 27, 2026 5:00 AM ET

Agomab Announces Results of Annual General Meeting